LGND  valuation analysis

Basics
Name: Ligand Pharmaceuticals Incorporated
Description: Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 03, 2021
Market cap: $2.43B (993rd)
Sales(TTM): $302.85M (1304th)
Earnings(TTM): -$2.98M (1062nd)

Value
FFER: 3.18 (why)
Actual price: $151.03
FFEThis is Ligand Pharmaceuticals Incorporated's the estimated price. FFEs are the denominator of the FFER ratio.: $47.86
Quantile: LGND is very expensive given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Ligand Pharmaceuticals Incorporated's earnings decreased from $629.30M to -$2.98M in the last year.
Earnings / MarketCap
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry
Sales / MarketCap
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry
Book / MarketCap
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry
Equity / Assets
Ligand Pharmaceuticals Incorporated
"Biotechnology" industry